Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



5 Medical Conditions Where Antibiotics May Be Unnecessary

Antibiotics such as Cipro (ciprofloxacin) and Amoxil (amoxicillin) are prescribed to treat a staggering range of different medical conditions, but their pervasive use could be reducing their efficacy in the long-term. The more these drugs are used, the greater the risk of antibiotic-resistant strain...

Read More

FDA announces improvements to Adverse Event Reporting System

The U.S. Food and Drug Administration (FDA) has announced improvements to its Adverse Event Reporting System (FAERS). The system is a database of reported medication issues, including product quality complaints leading to adverse events, medication error reports and other adverse event reports.&nbsp...

Read More

Lyrica CR tablets approved as pain management therapy for diabetics

Pfizer's Lyrica CR (pregabalin) extended-release tablets CV gained U.S. Food and Drug Administration (FDA) approval for use treating neuropathic pain experienced by patients with diabetic peripheral neuropathy, and for managing postherpetic neuralgia. <br /> The drug's safety and efficacy were estab...

Read More

Cheaper generic of contraceptive Depo-Provera reintroduced in the US

A generic version of the contraceptive injection Depo-Provera (medroxyprogesterone), likely to e cheaper than its branded counterpart, will be reintroduced into local pharmacies across the United States, Teva Pharmaceuticals has announced. <br /> Depo-Provera Contraceptive Injection (medroxyprogeste...

Read More

FDA grants for clinical trials 'may lead to lower drug prices'

Over the next four years, more than $22 million in grants have been awarded for clinical trials and research into treatment for patients with rare diseases, the U.S. Food and Drug Administration (FDA) has announced. In a statement released by the regulatory body, FDA Commissioner Scott Gottlieb MD s...

Read More

FDA approves new pediatric indication for Tracleer

The U.S. Food and Drug Administration has approved a new indication for the Actelion Pharmaceutical's drug Tracleer (bosentan). The medication may now be used to treat pediatric patients aged three and over who suffer from idiopathic or congenital pulmonary arterial hypertension (PAH). <br /> Tracle...

Read More